Novocure (NASDAQ: NVCR) announced today that management will participate in the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025. Ashley Cordova, Chief Executive ...

SHANGHAI & CAMBRIDGE, Mass. & ROOT, Switzerland, December 02, 2024--Zai Lab Limited (Nasdaq: ZLAB; HKEX: 9688) and Novocure (NASDAQ: NVCR) announced today that the pivotal, Phase 3 PANOVA-3 trial ...

BAAR, Switzerland--(BUSINESS WIRE)--$NVCR--Novocure (NASDAQ: NVCR) announced today that management will participate in the 43 rd Annual J.P. Morgan Healthcare ...

If you’re on the fence about investing in NovoCure Limited or Envista Holdings Corporation because you’re not sure how they measure up, it’s important to compare them on a few factors before making ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Former CFO of Cephalon Inc. and Philips Electronics North America will lead worldwide finance activities for growth oriented global oncology company Novocure Ltd., a commercial stage, private oncology ...

Cancer-targeting biotech NovoCure (NASDAQ: NVCR) had some highly positive news from the laboratory to deliver earlier this week, and investors couldn't grab hold of the stock fast enough.

From the beginning of 2024 through Dec. 3, shares of Novocure rose 112% higher. They've been soaring because, in addition to positive pancreatic cancer results, its Optune Lua device earned ...